Atypical hemolytic uremic syndrome: Unique clinical presentation linked to rare
CFHR5
mutation
EJHaem
.
2021 Sep 14;2(4):838-841.
doi: 10.1002/jha2.288.
eCollection 2021 Nov.
Authors
Sofia Menotti
1
,
Martino Donini
1
,
Giuseppina Pessolano
1
,
Livia Tiro
1
,
Maurizio Cantini
2
,
Jacopo Croce
1
,
Matteo Morandi
1
,
Filippo Mazzi
1
,
Katia Donadello
3
,
Oliviero Olivieri
1
,
Francesco Dima
4
,
Sergio De Marchi
1
,
Giovanni Gambaro
1
,
Enrico Polati
3
,
Lucia De Franceschi
1
Affiliations
1
Department of Medicine University of Verona and AOUI Verona Verona Italy.
2
Department of Transfusion Medicine University Hospital Verona Italy.
3
Department of Neuroscience, Biomedicine and Movement, Section of Clinical Biochemistry University of Verona and AOUI Verona Italy.
4
Department of Surgery, Dentistry, Paediatrics and Gynaecology University of Verona & AOUI Verona Italy.
PMID:
35845199
PMCID:
PMC9175842
DOI:
10.1002/jha2.288
No abstract available
Keywords:
complement; eculizumab; microangiopathy; plasmapheresis.
Publication types
Case Reports